Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Tallantyre

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Review of Neurotherapeutics|May 2, 2023
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosisAnnalisa Morgan, Emma Tallantyre, Daniel Ontaneda
Clinical Neurology and Neurosurgery|August 27, 2019
HSV-2 radiculitis: An unusual presentation mere days after genital infectionAli Adel Ne'ma Abdullah, Emma Tallantyre
Journal of Neurology|November 9, 2019
Early MRI predictors of prognosis in multiple sclerosisNikunj Davda, Emma Tallantyre, Neil P Robertson
The Lancet. Neurology|August 4, 2019
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosisDaniel Ontaneda, Emma Tallantyre, Tomas Kalincik, et al.
Journal of Neuroimmunology|May 27, 2026
Non-invasive biomarkers for Neurosarcoidosis: Complement activation as a tool for diagnosis and prognosisTarunya Arun, W John Watkins, Kirsten Baillie, et al.
Multiple Sclerosis and Related Disorders|August 8, 2021
The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UKLinford Fernandes, Christopher Martin Allen, Thomas Williams, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2019
Cerebrospinal fluid complement system biomarkers in demyelinating diseaseWioleta Milena Zelek, Dina Fathalla, Angharad Morgan, et al.
Multiple Sclerosis and Related Disorders|August 13, 2018
A contemporary study of mortality in the multiple sclerosis population of south east WalesKatharine Harding, Valerie Anderson, Owain Williams, et al.
Lancet (London, England)|May 28, 2026
Multi-arm multi-stage platform trials for neurological disease: accelerating progressParesh Malhotra, Suvankar Pal, Emma Tallantyre, et al.
JAMA Neurology|March 27, 2013
Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brainNiraj Mistry, Jennifer Dixon, Emma Tallantyre, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Review of Neurotherapeutics|May 2, 2023
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosisAnnalisa Morgan, Emma Tallantyre, Daniel Ontaneda
Clinical Neurology and Neurosurgery|August 27, 2019
HSV-2 radiculitis: An unusual presentation mere days after genital infectionAli Adel Ne'ma Abdullah, Emma Tallantyre
Journal of Neurology|November 9, 2019
Early MRI predictors of prognosis in multiple sclerosisNikunj Davda, Emma Tallantyre, Neil P Robertson
The Lancet. Neurology|August 4, 2019
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosisDaniel Ontaneda, Emma Tallantyre, Tomas Kalincik, et al.
Journal of Neuroimmunology|May 27, 2026
Non-invasive biomarkers for Neurosarcoidosis: Complement activation as a tool for diagnosis and prognosisTarunya Arun, W John Watkins, Kirsten Baillie, et al.
Multiple Sclerosis and Related Disorders|August 8, 2021
The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UKLinford Fernandes, Christopher Martin Allen, Thomas Williams, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2019
Cerebrospinal fluid complement system biomarkers in demyelinating diseaseWioleta Milena Zelek, Dina Fathalla, Angharad Morgan, et al.
Multiple Sclerosis and Related Disorders|August 13, 2018
A contemporary study of mortality in the multiple sclerosis population of south east WalesKatharine Harding, Valerie Anderson, Owain Williams, et al.
Lancet (London, England)|May 28, 2026
Multi-arm multi-stage platform trials for neurological disease: accelerating progressParesh Malhotra, Suvankar Pal, Emma Tallantyre, et al.
JAMA Neurology|March 27, 2013
Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brainNiraj Mistry, Jennifer Dixon, Emma Tallantyre, et al.
Pageof 3